Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00180141Phase 4Completed
A Phase 4 trial of pimecrolimus in atopic dermatitis (AD), sponsored by Technische Universität Dresden. Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00180141.